Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for SLGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 53.76M
March 31, 2026 58.55M
December 31, 2025 29.92M
September 30, 2025 34.59M
June 30, 2025 39.31M
March 31, 2025 27.06M
December 31, 2024 35.85M
September 30, 2024 42.98M
June 30, 2024 42.00M
March 31, 2024 39.91M
December 31, 2023 45.29M
September 30, 2023 49.86M
June 30, 2023 55.10M
March 31, 2023 49.04M
December 31, 2022 46.63M
September 30, 2022 51.29M
June 30, 2022 54.98M
March 31, 2022 56.06M
Date Value
December 31, 2021 69.19M
September 30, 2021 52.83M
June 30, 2021 46.40M
March 31, 2021 53.61M
December 31, 2020 59.16M
September 30, 2020 66.34M
June 30, 2020 74.63M
March 31, 2020 76.82M
December 31, 2019 61.30M
September 30, 2019 67.88M
June 30, 2019 63.38M
March 31, 2019 67.99M
December 31, 2018
September 30, 2018 80.64M
June 30, 2018 86.36M
March 31, 2018 89.94M
December 31, 2017 15.32M
September 30, 2017 22.78M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Teva Pharmaceutical Industries Ltd. 39.86B
RedHill Biopharma Ltd. --
MediWound Ltd. 71.88M
Purple Biotech Ltd. 14.17M
PolyPid Ltd. 15.23M

Total Assets (Quarterly) Related Metrics